**Liraglutide**, sold under the brand name **Victoza** among others, is an [anti-diabetic medication](https://en.wikipedia.org/wiki/Anti-diabetic_medication "Anti-diabetic medication") used to treat [type 2 diabetes](https://en.wikipedia.org/wiki/Type_2_diabetes "Type 2 diabetes"), [obesity](https://en.wikipedia.org/wiki/Obesity "Obesity"), and chronic [weight management](https://en.wikipedia.org/wiki/Weight_management "Weight management"). In diabetes it is a less preferred agent compared to [metformin](https://en.wikipedia.org/wiki/Metformin "Metformin"). Its effects on long-term health outcomes like [heart disease](https://en.wikipedia.org/wiki/Heart_disease "Heart disease") and life expectancy are unclear. It is given by [injection under the skin](https://en.wikipedia.org/wiki/Subcutaneous_injection "Subcutaneous injection"). Developed by [[Novo Nordisk]].